Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy Our results show that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results